Iron overload indices rise linearly with transfusion rate in patients with sickle cell disease

Blood

Volumn 115, Issue 14, 2010, Pages 2980-2981

  Inati, Adlette ^a,b,c   Musallam, Khaled M ^d   Wood, John C ^e   Taher, Ali T ^d  

^a RAFIC HARIRI UNIVERSITY HOSPITAL   (Lebanon)

^b Nini Hospital   (United States)

^c UNIVERSITY OF BALAMAND   (Lebanon)

^d AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; IRON;

ADOLESCENT; ADULT; BLOOD SAMPLING; BLOOD TRANSFUSION; CHILD; FEMALE; FERRITIN BLOOD LEVEL; HEMOLYSIS; HUMAN; INFORMED CONSENT; IRON OVERLOAD; LETTER; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SICKLE CELL ANEMIA; STEADY STATE;

EID: 77951034604     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-09-243568     Document Type: Letter

References (7)

1. Adamkiewicz TV, Abboud MR, Paley C, et al. Serum ferritin level changes in children with sickle cell disease on chronic blood transfusion are nonlinear and are associated with iron load and liver injury. Blood. 2009;114(21):4632- 4638.
2. St Pierre TG, Clark PR, Chua-Anusorn W. Measurement and mapping of liver iron concentrations using magnetic resonance imaging. Ann N Y Acad Sci. 2005;1054:379-385. (Pubitemid 43031045)
3. Anderson GJ. Mechanisms of iron loading and toxicity. Am J Hematol. 2007; 82(suppl 12):1128-1131.
4. Whitten CF. Studies on serum haptoglobin: a functional inquiry. N Engl J Med. 1962;266:529-534.
5. Sears DA, Anderson PR, Foy AL, Williams HL, Crosby WH. Urinary iron excretion and renal metabolism of hemoglobin in hemolytic diseases. Blood. 1966; 28(5):708-725.
6. Vichinsky E, Butensky E, Fung E, et al. Comparison of organ dysfunction in transfused patients with SCD or beta thalassemia. Am J Hematol. 2005;80(1): 70-74. (Pubitemid 41254272)
7. Cohen AR, Glimm E, Porter JB. Effect of transfusional iron intake on response to chelation therapy in beta-thalassemia major. Blood. 2008;111(2):583-587.